Enveric Hires Fish & Richardson To Defend IP Against Petition Claiming Its Patent Contains Claims Relevant To AbbVie's $1.2B Bretisilocin Acquisition

Why is Paramount planning mass layoffs? How will China’s slowing GDP impact global markets? What caused the recent surge in Toyo Tire profits? Why is Kering selling its beauty division to L’Oréal? How is Tesla's new CEO pay package affecting investors? What’s behind the Louvre’s recent jewelry heist? How are US-China trade tensions affecting oil prices?

Enveric Hires Fish & Richardson To Defend IP Against Petition Claiming Its Patent Contains Claims Relevant To AbbVie's $1.2B Bretisilocin Acquisition

benzinga.com/partner/biotech/25/10/48232600/enveric-hires-fish-richardson-to-defend-ip-against-petition-claiming-its-patent-contains-claims-r

Enveric Biosciences (NASDAQ:ENVB) recently announced that it has hired intellectual property powerhouse Fish and Richardson P.C. to contest a Post-Grant Review (PGR) petition filed by rival Gilgamesh Pharmaceuticals against Enveric's issued U.S. Patent No. 12,138,276 (the '276 patent)…

This story appeared on benzinga.com, 2025-10-15 17:11:17.